Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Regenxbio inc. symbols : BHC save search
Macular Degeneration Treatment Global Market to Reach $10.65 Billion by 2026 at a CAGR of 7.15%
Published: 2022-09-14 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
|
| O: -4.98%
H: 7.63%
C: 2.67%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.55%
H: 0.42%
C: -0.72%
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
|
| O: -0.6%
H: 0.41%
C: -0.76%
BHC | $8.56 0.35% 0.47% 1.1M
|
Health Technology
|
| O: 0.41%
H: 11.64%
C: 6.22%
RGNX | $16.04 0.88% 0.93% 430K
|
Health Technology
|
| O: 0.38%
H: 2.53%
C: 1.48%
treatment global macular market
Global Macular Degeneration Treatment Market Report (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-06-09 (Crawled : 18:00) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.49%
H: 0.47%
C: -1.59%
BHC | $8.56 0.35% 0.47% 1.1M
|
Health Technology
|
| O: -0.89%
H: 0.67%
C: -6.05%
RGNX | $16.04 0.88% 0.93% 430K
|
Health Technology
|
| O: -0.75%
H: 0.53%
C: -3.07%
treatment report macular market
Macular Degeneration Treatment Market size worth $ 11.98 Billion, Globally, by 2028 at 6.01% CAGR: Verified Market Research®
Published: 2022-02-14 (Crawled : 09:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: -0.81%
BHC | $8.56 0.35% 0.47% 1.1M
|
Health Technology
|
| O: -0.48%
H: 1.52%
C: -1.08%
RGNX | $16.04 0.88% 0.93% 430K
|
Health Technology
|
| O: 0.92%
H: 0.87%
C: -0.91%
research treatment macular
Clearside Biomedical Features FDA-Approved XIPERE™ in Multiple Presentations at the American Academy of Ophthalmology 2021 and American Uveitis Society Meetings
Published: 2021-11-16 (Crawled : 12:30) - globenewswire.com
BHC | $8.56 0.35% 0.47% 1.1M
|
Health Technology
|
| O: 0.52%
H: 0.26%
C: -1.04%
RGNX | $16.04 0.88% 0.93% 430K
|
Health Technology
|
| O: -17.59%
H: 2.67%
C: 1.05%
CLSD | News P | $1.34 -2.19% -3.01% 200K
|
Health Technology
|
| O: -2.56%
H: 0.0%
C: 0.0%
presentation fda xipere fda approval
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.